On the other hand, targeting m6A “erasers” such as ALKBH5 or FTO, which regulate immune checkpoint molecule expression by demethylating m6A modifications, could suppress immune suppression and promote anti-tumor immune responses. The gene discussed is ALKBH5; the disease is neoplasm.